Lots of potential. Great volume coming in.

2 ม.ค. 2019

Company is heavily focused on CBD, and has a vertical integration where it's able to sell to the US and UK.

ISOL has been buying up companies, building a lot of partnerships, and actually turning a profit.

RSI is diverging quite a bit, volume is coming in quite nicely.
Looks like a good buy and hold for me.

7 ม.ค. 2019

บันทึก

Trade is going well so far, setting a tight SL, don't care where it goes, just want to preserve capital in light of more fundamental research:
seekingalpha.com/article/4164688-isodiol-mjna-2_0-expect-massive-dilution-arms-length-transactions